他克莫司联合低剂量激素治疗儿童难治性肾病综合征临床疗效(附16例报告)

doi:10.13481/j.1671-587x.20180531

吉林大学学报(医学版) ›› 2018, Vol. 44 ›› Issue (05): 1056-1060.doi: 10.13481/j.1671-587x.20180531

他克莫司联合低剂量激素治疗儿童难治性肾病综合征临床疗效(附16例报告)

张欣¹, 李青梅², 马青山², 周娜³

1. 吉林大学第一医院药学部, 吉林长春 130021;
2. 吉林大学第一医院小儿肾病科, 吉林长春 130021;
3. 吉林大学口腔医院药剂科, 吉林长春 130021

收稿日期:2018-02-02 出版日期:2018-09-28 发布日期:2018-11-20
通讯作者: 马青山,教授,硕士研究生导师(Tel:0431-88783667,E-mail:maqs@jlu.edu.cn);周娜,主管药师(Tel:0431-88796019,E-mail:happy_potato531@163.com) E-mail:maqs@jlu.edu.cn;happy_potato531@163.com
作者简介:张欣(1983-),男,吉林省长春市人,主管药师,医学博士,主要从事儿童临床合理用药方面的研究。
基金资助:
吉林省发展和改革委员会纵向项目资助课题（201005）

Clinical efficacy of tacrolimus combined with low dose of corticosteroids in treatment of children with refractory nephritic syndrome:A report of 16 cases

ZHANG Xin¹, LI Qingmei², MA Qingshan², ZHOU Na³

1. Department of Pharmacy, First Hospital, Jilin University, Changchun 130021, China;
2. Department of Pediatric Nephrology, First Hospital, Jilin University, Changchun 130021, China;
3. Department of Pharmacy, Stomatology Hospital, Jilin University, Changchun 130021, China

Received:2018-02-02 Online:2018-09-28 Published:2018-11-20

摘要/Abstract

摘要： 目的：探讨他克莫司联合低剂量醋酸泼尼松治疗儿童难治性肾病综合征（RNS）的临床疗效和安全性，并观察地尔硫卓对他克莫司血药浓度的影响。方法：选择儿科住院的RNS患儿16例，应用他克莫司（0.10~0.15 mg·kg^-1·d^-1）联合低剂量醋酸泼尼松（1.0~2.0 mg·kg^-1·d^-1）治疗，监测患儿治疗过程中他克莫司浓度，记录患儿治疗前及治疗后2、4、8、12和24周时的24 h尿蛋白定量（UP）、血浆白蛋白（Alb）和肌酐等6项指标。结果：16例患儿中完全缓解9例，部分缓解5例，无效2例，总有效率94%。治疗24周后，16例患儿24 hUP较治疗前明显降低（Z=-3.516，P<0.01）；血浆Alb水平较治疗前明显升高（Z=-3.516，P<0.01）。治疗2周时患儿总胆固醇和甘油三酯水平较治疗前明显下降（Z=-2.223，P<0.05；Z=-3.464，P<0.01）。8例患儿出现他克莫司血药浓度偏低，给予地尔硫卓后血药浓度均提升至有效浓度范围。患儿在治疗过程中肌酐和尿素氮等指标均在正常范围内平稳波动。结论：他克莫司联合低剂量激素的免疫抑制方案治疗儿童RNS安全有效，地尔硫卓能够有效提高他克莫司的血药浓度。

关键词: 他克莫司, 难治性肾病综合征, 醋酸泼尼松, 地尔硫卓, 儿童

Abstract: Objective:To observe the clinical efficacy and safety of tacrolimus(TAC) combined with low dose of corticosteroids in the treatment of the children with refractory nephrotic syndrome(RNS),and to investigate the effect of diltiazem on the blood concentration of TAC. Methods:A total of 16 hospitalized children with refractory nephrotic syndrome(RNS)were selected.All patients were treated with TAC(0.10-0.15 mg·kg^-1·d^-1)combined with low dose of corticosteroids(l.0-2.0 mg·kg^-1·d^-1).The concentrations of TAC of the children during the treatment process were monitored.The 24 h urine protein quantitative(UP),plasma albumin (Alb),creatinine and other 6 indexes were recorded before treatment and 2,4,8,12 and 24 weeks after treatment. Results:In 16 cases,9 cases were completely relieved,5 cases were partially relieved,and 2 cases were invalid;the total efficiency was 94%.The 24 h UP of 16 children at 24 weeks after treatment was significantly decreased compared with before treatment(Z=-3.516,P<0.01);the plasma Alb level of the children was significantly increased compared with before treatment(Z=-3.516,P<0.01).The total cholesterol and triglyceride levels at 2 weeks after treatment were decreased significantly compared with before treatment(Z=-2.223,P<0.05;Z=-3.464,P<0.01).Eight patients had low blood concentration of TAC,and it was increased to an effective concentration after treated with diltiazem.In the course of treatment,creatinine,urea nitrogen and other indexes of the patients were fluctuated in a normal range. Conclusion:TAC combined with low dose of corticosteroids for treatment of RNS is safe and effective,and diltiazem can effectively increase the blood concentration of TAC.

Key words: tacrolimus, refractory nephrotic syndrome, prednisone aectate, diltiazem, children

中图分类号:

R725.7

张欣, 李青梅, 马青山, 周娜. 他克莫司联合低剂量激素治疗儿童难治性肾病综合征临床疗效(附16例报告)[J]. 吉林大学学报(医学版), 2018, 44(05): 1056-1060.

ZHANG Xin, LI Qingmei, MA Qingshan, ZHOU Na. Clinical efficacy of tacrolimus combined with low dose of corticosteroids in treatment of children with refractory nephritic syndrome:A report of 16 cases[J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1056-1060.

参考文献

[1] 李冉,辛华雯.他克莫司治疗儿童难治性肾病综合征的研究进展[J].中国药师,2017,20(12):2228-2232.
[2] Gulati S,Prasa N,Sharma RK,et al.Tacrolimus B new therapy for steroid-resistant nephrotic syndrome in Children[J].Nephrol Dial Transplant,2008,23:910-913.
[3] Greenbaum LA,Benndorf R,Smoyer WE.Childhood nephrotic syndrome-current and future therapies[J].Nat Rev Nephrol,2012, 8(8):445-448.
[4] Chen Y,Schieppati A,Cai G,et al.Immunosuppression for Membranous Nephropathy:A Systematic Review and Meta-Analysis of 36 Clinical Trials[J].Clin J Am Soc Nephrol,2013,8(5):787-796.
[5] 周逸雯,周琰,吴炯,等.CYP3A4、CYP3A5和CYP2D6基因单核苷酸多态性对肾移植术后稳定期患者他克莫司代谢的影响[J].检验医学,2015,30(11):1091-1095.
[6] 易鑫,汪江林,周亚男,等.地尔硫卓单用及与氨氯地平或非洛地平联用对肾移植受者他克莫司血药浓度/剂量比的影响[J].中国药房,2015,26(15):2038-2041.
[7] 中华医学会儿科分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-747.
[8] 中华医学会儿科学分会肾脏学组.儿童常见肾脏疾病诊治循证指南(一):激素敏感、复发/依赖肾病综合征诊治循证指南(试行)[J].中华儿科杂志,2009,47(3):167-170.
[9] Cruz JL,Wolff ML,Vanderman AJ,et al.The emerging role of tacrolimus in myasthenia gravis[J].Ther Adv Neurol Disord,2015,8(2):92-103.
[10] Aydogan M,Yologlu N,Gacar G,et al.Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome:Increase in number of Treg cells after desensitization[J].J Allergy Clin Immunol,2013,132(2):478-480.
[11] Chen M,Li H,Li XY,et al.Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy:a multicenter randomized controlled trial[J].Am J Med Sci,2010, 339(3):233-238.
[12] Cui W,Lu X,Min X,et al.Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy[J].Braz J Med Biol Res,2017,50(4):e5976.
[13] 张艳敏,宋晓翔,王丽峰,等.他克莫司治疗50例儿童激素耐药型肾病综合征的临床研究[J].中华临床医师杂志,2016,10(23):3526-3529.
[14] 周优丽,沈增晖,姚云,等.他克莫司联合激素对儿童激素耐药难治性肾病综合征的疗效研究[J].儿科药学杂志,2016,22(3):21-23.
[15] Bhimma R,Adhikari M,Asharam K,et al. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus[J]. Am J Nephrol,2006,26(6):544-551.
[16] Haddad M,Lau K,Butani L.Remission of membranoproliferative glomerulonephritis type Ⅰ with the use of tacrolimus[J].Pediatr Nephrol,2007,22(10):1787-1791.
[17] Qin HZ,Liu L, Liang SS,et al. Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients[J].BMC Nephrol,2017,18(2):2-9.
[18] Westhoff TH,Giet M.Tacrolimus in the treatment of idiopathic nephrotic syndrome[J].Expert Opin Investiq Drugs,2007,16(7):1099-1110.
[19] 龚丽娴.地尔硫卓致他克莫司血药浓度升高2例[J].医学信息, 2010,23(6):1650.
[20] 李明,宋艳,高雅婷,等.肾移植患者合并用药对他克莫司血药浓度的影响[J].中国合理用药探索杂志,2017,14(4):36-40.
[21] 陆迪菲,袁戈恒,郭晓蕙.库欣综合征患者术后管理:糖皮质激素替代治疗[J].中国实用内科杂志,2018,38(7):611-614.
[22] 黎晓红.长程大量应用糖皮质激素的不良反应及防治进展[J].临床合理用药杂志,2016,3(9):174-175.
[23] 任东亮,张效功,陈清亮.他克莫司联合小剂量激素治疗儿童难治性肾病综合征的临床疗效观察[J].中国现代药物应用杂志,2015,9(18):114-115.

他克莫司联合低剂量激素治疗儿童难治性肾病综合征临床疗效(附16例报告)

Clinical efficacy of tacrolimus combined with low dose of corticosteroids in treatment of children with refractory nephritic syndrome:A report of 16 cases

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	雷晓燕, 孙永红, 陈星星, 高霞, 宋元春, 赛依帕, 刘璟, 袁宏. 乙型肝炎病毒相关性肾小球肾炎患儿血清中HBV-cccDNA水平检测及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(06): 1256-1262.
[2]	孙铭徽, 陈香儒, 刘翔宇, 贾玉玺, 姜日花. CO₂点阵激光联合他克莫司治疗局限型白癜风的临床疗效[J]. 吉林大学学报(医学版), 2018, 44(05): 1061-1064.
[3]	金润浩, 徐忠福, 全贞玉, 李庆, 韩春姬. 吉林省延吉市儿童和青少年超重/肥胖现况调查及其影响因素分析[J]. 吉林大学学报(医学版), 2018, 44(05): 1078-1085.
[4]	王明睿, 翟秀宇, 王钢, 张文岚, 高宝山, 周洪澜, 傅耀文. CYP3A5基因多态性对肾移植术后患者他克莫司代谢的影响[J]. 吉林大学学报(医学版), 2018, 44(03): 537-542.
[5]	许可, 王斌, 刘钦毅, 张为众. 改良腱鞘麻醉在小儿手外伤治疗中的临床应用[J]. 吉林大学学报(医学版), 2018, 44(03): 610-614.
[6]	邹飞, 程志华, 张玉影, 马可. 槐杞黄颗粒辅助治疗非急性发作期哮喘患儿的疗效评价[J]. 吉林大学学报(医学版), 2018, 44(03): 597-603.
[7]	窦邦现, 李红卫, 程富礼, 白晨平. 指动脉轴型皮瓣扩容矫形治疗WasselⅢ~Ⅴ型复拇指畸形的临床疗效(附14例报告)[J]. 吉林大学学报(医学版), 2018, 44(03): 620-623.
[8]	郭丽双, 刘金香, 王晶华, 潘璐, 徐萌, 刘聪聪, 杨思睿. 甲泼尼龙脉冲联合吗替麦考酚酯治疗儿童系统性红斑狼疮临床疗效分析[J]. 吉林大学学报(医学版), 2018, 44(02): 368-373.
[9]	罗红芳, 龙月婷, 梁建华, 姜志花, 李书梅. 贵州省黔东南州少数民族地区苗族和侗族儿童地中海贫血的筛查及其特点[J]. 吉林大学学报(医学版), 2017, 43(03): 646-650.
[10]	黎文静, 徐萌, 郭丽双, 杨思睿, 刘金香. 儿童过敏性紫癜患者肺炎支原体抗体的检测及其临床意义[J]. 吉林大学学报(医学版), 2017, 43(01): 155-158.
[11]	司鹤南, 钟淑霞, 周俊峰, 姚蕾, 刘媛媛, 宋洋, 李珊山. 271例儿童白癜风患者的临床特点及危险因素分析[J]. 吉林大学学报(医学版), 2017, 43(01): 147-150.
[12]	周广宇, 郭莹, 张力, 王雪婷, 吴晨. 他克莫司联合激素治疗特发性膜性肾病疗效及其抗PLA2R抗体对治疗的反应[J]. 吉林大学学报(医学版), 2016, 42(05): 937-941.
[13]	齐玲, 王玮瑶, 张艳春, 蔡尚霞, 杨宁江, 刘晓丽. 肿瘤坏死因子α信号传导通路在儿童哮喘发病机制中的作用[J]. 吉林大学学报(医学版), 2015, 41(02): 379-382.
[14]	刘晓丹, 申亚利, 徐林燕, 杜柯凝. 沙尘天气与儿童呼吸系统疾病日门诊量的关联性分析[J]. 吉林大学学报(医学版), 2015, 41(01): 190-194.
[15]	卢爱桃，郭卫东，李昕，王文瑞，跃华，于晶峰. 2009－2012年内蒙古自治区急性呼吸道感染患儿呼吸道合胞病毒感染的检测及分布特征[J]. 吉林大学学报(医学版), 2014, 40(02): 433-436.